Net marj · 2025 mali yılı
| 1 | United TherapeuticsUTHR | %41,9 |
|---|---|---|
| 2 | PTC TherapeuticsPTCT | %39,5 |
| 3 | NovavaxNVAX | %39,2 |
| 4 | Acadia PharmaceuticalsACAD | %36,5 |
| 5 | ExelixisEXEL | %33,7 |
| 6 | Novo Nordisk A SNVO | %33,1 |
| 7 | Vertex PharmaceuticalsVRTX | %32,9 |
| 8 | Royalty PharmaRPRX | %32,4 |
| 9 | Eli LillyLLY | %31,7 |
| 10 | Regeneron PharmaceuticalsREGN | %31,4 |